Pharmacists in Kewaskum, WI Accepting Medicare
4 Pharmacists found. Showing 1 - 4
 Dr. Tamara Carr Ravn, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 927 Fond Du Lac Ave, Kewaskum, WI 53040 Phone: 262-626-4222 Fax: 262-626-2109 |
Miss Erika Buchel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Fond Du Lac Ave, Kewaskum, WI 53040 Phone: 262-477-1700 |
Mrs. Kathryn Anne Bublitz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Fond Du Lac Ave, Kewaskum, WI 53040 Phone: 262-477-1700 |
Dr. Erin Orth, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 901 Fond Du Lac Ave, Kewaskum, WI 53040 Phone: 262-477-1700 |
News Archive
Xeltis receives PEI conditional approval to initiate tissue-engineered cardiovascular graft study
Xeltis, a biomedical technology company developing growing, living and self-healing cardiovascular implants using tissue-engineering technology, has announced conditional approval by the Paul Erlich Institute (PEI) in Germany to commence the first clinical study of its tissue-engineered cardiovascular grafts.
TSRI scientists find drug candidates that can prevent degeneration of brain cells in Parkinson's
In a pair of related studies, scientists from the Florida campus of The Scripps Research Institute have shown their drug candidates can target biological pathways involved in the destruction of brain cells in Parkinson's disease.
Educating communities about evidenced-based beneļ¬ts of music therapy
As Lori Gooding, University of Kentucky's music therapy director, walks into Joshua Diven's patient room at Kentucky Children's Hospital (KCH), the 3-year-old's face lights up. This is the second time that Gooding and Shane Swezey, a music therapy intern, have visited Diven in the past four days. Gooding has also worked with Joshua on previous visits to KCH.
Colorectal tumors present epigenetic heterogeneity, study finds
A new study led by Dr. Manel Esteller, Director of the Epigenetics and Cancer Biology Program of Bellvitge Biomedical Research Institute, ICREA researcher and Professor of Genetics at University of Barcelona discovers that colorectal tumors present epigenetic heterogeneity that relates to the clinical course of the disease.
Solos Endoscopy management approves 2011 recapitalization plan
Solos Endoscopy, Inc. is pleased to announce that the Company's management has approved its 2011 recapitalization plan in order to position itself for growth over the next twelve months. The recapitalization plan is designed to increase financial flexibility for Solos and its shareholders.
› Verified 2 days ago